ESC Premium Access

Risk factors for heart failure after doxorubicin chemotherapy for breast- or colorectal cancer

Congress Presentation

About the speaker

Doctor Gyorgy Fogarassy

Balatonfured State Cardiology Hospital, Balatonfured (Hungary)
0 follower

8 more presentations in this session

First Australian registry of patients with wild type cardiac amyloidosis (ATTRwt): Queensland experience.

Speaker: Doctor M. Burrage (Robina, AU)

Thumbnail

Clinical characteristics of ST-elevation and non-ST-elevation types in patients with takotsubo syndrome -a multicenter registry in eight-university hospitals in East Japan

Speaker: Assistant Professor M. Yoshizawa (Morioka, JP)

Thumbnail

Myocardial bridging and left ventricular thrombus formation in patients with takotsubo cardiomyopathy

Speaker: Doctor B. Schneider (Luebeck, DE)

Thumbnail

Predictors of heart failure hospitalizations in hypertrophic cardiomyopathy

Speaker: Doctor A. Cecconi (Madrid, ES)

Thumbnail

Non-linear dynamics of heart rate variability independently predicts all-cause mortality of patients with Sarcoidosis

Speaker: Doctor E. Gialafos (Athens, GR)

Thumbnail

Access the full session

Cardiomyopathies: understanding the enemy

Speakers: Doctor G. Fogarassy, Doctor M. Burrage, Assistant Professor M. Yoshizawa, Doctor B. Schneider, Doctor A. Cecconi...
Thumbnail

About the event

Image

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb